Edgewise Therapeutics
Kostas Kotselas, CPA has a background in finance and accounting, with experience as an Audit Senior and Audit Associate at Baker Tilly US before becoming a Senior Manager at Edgewise Therapeutics. Kotselas holds a Bachelor of Business Administration (B.B.A.) degree in Accounting and Finance from the University of Wisconsin-Milwaukee. At Edgewise Therapeutics, a clinical-stage biopharmaceutical company, Kotselas serves as the Assistant Controller managing finance and accounting operations.
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.